Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
What is the ticker symbol for Adial Pharmaceuticals Inc? What does ADIL stand for in stocks?
ADIL is the stock ticker symbol of Adial Pharmaceuticals Inc. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of Adial Pharmaceuticals Inc (ADIL)?
As of Wed Nov 20 2024, market cap of Adial Pharmaceuticals Inc is 6.41 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of ADIL stock?
You can check ADIL's fair value in chart for subscribers.
Is Adial Pharmaceuticals Inc a good stock to buy?
The fair value guage provides a quick view whether ADIL is over valued or under valued. Whether Adial Pharmaceuticals Inc is cheap or expensive depends on the assumptions which impact Adial Pharmaceuticals Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ADIL.